Symptoms of attention-deficit/hyperactivity disorder in Down syndrome: effects of the dopamine receptor D4 gene.

Rice et al. (2015) looked at the dopamine receptor D4 gene in children with Down syndrome. They wanted to know if a common variant called the 7-repeat allele shows up more often in kids who also have ADHD symptoms. Parents and trained observers filled out rating scales. The kids also tried short lab games that test self-control.

Children who carried the 7-repeat allele scored higher on adult-rated ADHD checklists. The same kids did not score worse on the lab games. The gene link showed only in everyday settings like home or school, not inside the testing room.

Sasson et al. (2022) later surveyed families and found that DS children with ADHD signs also have more sleep, allergy, and seizure issues. The 2015 gene finding helps explain why those problems cluster: dopamine pathways are involved. Higgins et al. (2021) gave methylphenidate to 21 DS children with ADHD; three-quarters improved. Their drug test builds on the 2015 gene work by showing the same dopamine system can be tapped for treatment. Soltani et al. (2025) tracked kids for six months and saw that weak working memory, not the gene itself, predicted later inattention ratings. The studies together tell a story: a gene raises risk, daily life reveals it, and practice can still move the needle.

You now have a second layer to add to your Down-syndrome behavior screen. Ask about family history of ADHD and, if possible, note DRD4 status. When caregivers report high activity or short attention, think medical plus behavioral: check sleep, seizures, allergies. If you plan a stimulant trial, the 2021 case series says most kids tolerate it, so you can present data to hesitant families. Finally, train working memory anyway; Soltani et al. (2025) show it still predicts future focus even after genes are set.